Clinical Trial Update: StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study [Phase 2]

View source ↗

Summary

Pilot Phase 2 trial evaluating statins for reducing venous thromboembolism events.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Statins

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Venous Thromboembolism | Phase 2 | Status: UNKNOWN